Diffuse liver disease - 01/09/11
, Koenraad J Mortele, MDRésumé |
Advances in imaging technology and development of liver-specific contrasts agents have significantly increased the role of radiology in the detection and characterization of processes diffusely involving the liver. Tailored magnetic resonance (MR) imaging sequences allow an accurate detection of many storage and metabolic diseases. Faster scanning techniques available with both computed tomography (CT) and MR provide, by assessing contrast dynamics, sufficient information for the characterization of diffuse neoplastic and vascular disorders. Characteristic changes in attenuation on CT, signal intensity on MR, and enhancing features can be used to diagnose specific diffuse diseases. This article focuses on the current role of imaging in the detection and characterization of diffuse liver disorders. Recent developments that have amplified the role of noninvasive diagnostic evaluation of these conditions are especially highlighted.
Le texte complet de cet article est disponible en PDF.Plan
Vol 6 - N° 1
P. 181-201 - février 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
